For most patients with CKD, the approach is to start with an SGLT2 inhibitor as the kidney-protective foundation, then consider adding a GLP-1 if the patient also has obesity, needs additional blood sugar control, or has elevated cardiovascular risk
Average weight loss at week 17 1 Average decrease in blood pressure 1 Average decrease in BMI 2 Overall program rating by patients 2 Anyone who has tried to diet and lose weight knows how hard it is to find long-term success
Within the first 24 hours, you should avoid strenuous exercise, extensive sun or heat exposure, and alcoholic beverages
Individual differences : Age, gut health, and enzyme levels vary among people, affecting absorption rates
Months 5-6: Stabilization and Long-Term Planning The final phase of six-month protocols focuses on stabilizing benefits and planning for long-term maintenance
104 GLP-1RAs have been shown to enhance endothelial cell function through anti-inflammatory and vasodilatory mechanisms